Skip to content

Clinical trials

Phase 3 Thromboembolism trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Phase 3 Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20064
20071
20081
20091
20121
20144
20161
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Boehringer Ingelheim4
Janssen Research & Development, LLC2
McMaster University2
Daiichi Sankyo1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism15
Stroke5
Atrial Fibrillation4
Venous Thromboembolism4
Hemorrhage3
Pulmonary Embolism3
Thrombosis3
Venous Thrombosis3
Ischemic Attack, Transient2
Arrhythmias, Cardiac1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.